These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 779092)

  • 1. [Use of verospiron in chronic nonspecific lung diseases].
    Komarov FI; Daniliak IG; Tuzel'baev NK
    Ter Arkh; 1975; 47(3):121-5. PubMed ID: 779092
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of nitrates on patients with chronic nonspecific lung diseases].
    Pribylova NN; Barbashina TA; Shkliarova BS
    Klin Med (Mosk); 1988 Mar; 66(3):47-51. PubMed ID: 3392923
    [No Abstract]   [Full Text] [Related]  

  • 3. [External respiratory function in combined therapy of chronic nonspecific lung diseases and the bronchospasm syndrome].
    Usenko IuD; Babich GG; Petrova IE; Filippova ES
    Vrach Delo; 1981 May; (5):19-21. PubMed ID: 6789554
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of adrenaline, ephedrine, and atropine on the function of the organs of external respiration in patients with chronic nonspecific lung diseases].
    Shpyneva LV
    Ter Arkh; 1969; 41(10):34-9. PubMed ID: 5359343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dimexide sanative treatment of the bronchial tree in chronic nonspecific lung diseases].
    Kirkin EM; Nikolaev GA
    Voen Med Zh; 1981 Oct; (10):59-60. PubMed ID: 7303517
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of lasolvan on mucociliary transport in patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Klin Med (Mosk); 1988 Mar; 66(3):45-7. PubMed ID: 3392922
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of anthranilic acid derivatives in the overall treatment of chronic nonspecific lung diseases in children].
    Sydel'nikov VM; Sriebnyĭ MM
    Pediatr Akus Ginekol; 1979; (3):7-10. PubMed ID: 379790
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of calcium antagonists in the treatment of patients with chronic nonspecific lung diseases].
    Vereshchagina GN; Vasilenko GP; Kuleshova TV
    Klin Med (Mosk); 1988 Mar; 66(3):41-4. PubMed ID: 3392921
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of interstitial electrophoresis in the combined treatment of patients with tuberculosis and nonspecific lung diseases].
    Bilyk MA; Zhuk VV
    Vrach Delo; 1985 Oct; (10):92-5. PubMed ID: 4090446
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of levamisole in chronic nonspecific lung diseases].
    Shmelev EI; Bumagina TK; Miterev IuG; Zamchiĭ AA; Kononova AN
    Sov Med; 1980; (11):26-31. PubMed ID: 7444640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of the clinical and respiratory functional effects of a mucolytic-antibiotic preparation in chronic bronchopulmonary diseases. Controlled double-blind single code studies].
    Alberto S; Colongo PG; Brusasco L; Frigerio G
    Minerva Med; 1968 Jul; 59(53):2995-3002. PubMed ID: 5671380
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination of Noleptan and oxyethyltheophylline for the oral therapy in "multilocal trial"].
    Sahi J; Tschakert H
    Med Monatsschr; 1976 Sep; 30(9):408-13. PubMed ID: 790142
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiotonic therapy of chronic nonspecific lung diseases].
    Dudka PF; Zozulia AA
    Vrach Delo; 1979 Oct; (10):94-6. PubMed ID: 516648
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with spironolactone in pediatrics.
    Buck ML
    Ann Pharmacother; 2005 May; 39(5):823-8. PubMed ID: 15811903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of "dry" carbon dioxide baths on external respiratory function in patients with chronic nonspecific lung diseases and bronchospastic syndrome].
    Zhirov VP
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (2):20-3. PubMed ID: 6408800
    [No Abstract]   [Full Text] [Related]  

  • 16. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
    de los Rios JC; Ortíz Feijoo J; Otero Cagide F
    Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic effects of propranolol in chronic lung diseases.
    Lockhart A; Schrijen F; Salmon D; Andrada L; Peslin R
    Clin Sci; 1967 Aug; 33(1):101-10. PubMed ID: 6059290
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of aerosol dexamethasone isonicotinate (author's transl)].
    Dierckx JP; Gillard C; Gossart R
    Acta Tuberc Pneumol Belg; 1974; 65(2):219-27. PubMed ID: 4608669
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospective trends in treating gastroduodenal ulcers and chronic nonspecific lung diseases in their combined course].
    Birg NA
    Ter Arkh; 1983; 55(3):94-7. PubMed ID: 6134349
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of bisolvon in nonspecific diseases of the respiratory organs].
    Komarov FI; Daniliak IG; Guliaeva FE
    Vrach Delo; 1975 Dec; (12):50-2. PubMed ID: 782038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.